![Michael Wyzga](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Michael Wyzga
Président chez
GENSIGHT BIOLOGICS S.A.
Fortune : 26 094 $ au 31/05/2026
Profil
Mr. Michael S.
Wyzga is an Independent Director at Tvardi Therapeutics, Inc., an Independent Director at Carina Biotech Ltd., a Chairman at Mereo BioPharma Group Plc, a Lead Independent Director at X4 Pharmaceuticals, Inc., a President at Bioleap, Inc. (Florida), a Chairman at Gensight Biologics SA and a Chairman & Chief Financial Officer at Sporos Bioventures LLC.
He is on the Board of Directors at Tvardi Therapeutics, Inc., Carina Biotech Ltd., Glyscend, Inc., X4 Pharmaceuticals, Inc., Dohmen Co. and International Institute of New England, Inc. Mr. Wyzga was previously employed as an Independent Director by Invivyd, Inc., a Chairman by Arsanis, Inc., an Independent Director by LogicBio Therapeutics, Inc., a Chairman by X4 Pharmaceuticals, Inc. /Old/, an Independent Director by EXACT Sciences Corp., a Chief Financial Officer by Kew, Inc., a Member-Supervisory Board by Prosensa Holding NV, an Independent Director by Akebia Therapeutics, Inc., an Independent Director by OncoMed Pharmaceuticals, Inc., an Independent Director by Idenix Pharmaceuticals LLC, a President, Chief Executive Officer & Director by Radius Health, Inc., a Chief Financial Officer by Aura Biosciences, Inc., a Chief Financial Officer & Executive VP-Finance by Genzyme Corp., a Chief Financial Officer by Sovereign Hill Software, Inc., a Chief Financial Officer & Vice President by CacheLink Corp., a Vice President-Finance by Lotus Development Corp., and a Principal by Digital Equipment Corp.
He also served on the board at Tvardi Therapeutics, Inc. (Old), Altus Pharmaceuticals, Inc. and The Wang Center For The Performing Arts, Inc. He received his undergraduate degree from Suffolk University and an MBA from Providence College.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 01/03/2026 | 4 055 ( 0 % ) | 17 477 $ | 31/05/2026 | |
| 26/03/2026 | 125 250 ( 0,02 % ) | 8 617 $ | 31/05/2026 | |
-.--% | 09/06/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
Postes actifs de Michael Wyzga
| Sociétés | Poste | Début |
|---|---|---|
| GENSIGHT BIOLOGICS S.A. | Président | 01/02/2016 |
| X4 PHARMACEUTICALS, INC. | Directeur/Membre du Conseil | 12/08/2025 |
| MEREO BIOPHARMA GROUP PLC | Président | 17/05/2022 |
Carina Biotech Pty Ltd.
 Carina Biotech Pty Ltd. BiotechnologyHealth Technology Develops chimeric antigen receptor T-cell therapies to treat cancers | Directeur/Membre du Conseil | 05/06/2023 |
Glyscend, Inc.
 Glyscend, Inc. Pharmaceuticals: MajorHealth Technology Develops oral metabolic therapeutics for the treatment of type 2 diabetes | Directeur/Membre du Conseil | 30/03/2023 |
Sporos Bioventures, Inc.
 Sporos Bioventures, Inc. Medical/Nursing ServicesHealth Services Provides healthcare services | Fondateur | - |
Bioleap, Inc. (Florida)
 Bioleap, Inc. (Florida) Engineering & ConstructionIndustrial Services Provides engineering services | Fondateur | 01/11/2013 |
International Institute of New England, Inc.
 International Institute of New England, Inc. Services to the Health IndustryHealth Services Operates charitable organization for refugees and immigrants | Directeur/Membre du Conseil | - |
Dohmen Co.
 Dohmen Co. Data Processing ServicesTechnology Services Provides outsourced healthcare services | Directeur/Membre du Conseil | 01/01/2010 |
Anciens postes connus de Michael Wyzga
| Sociétés | Poste | Fin |
|---|---|---|
| ░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░░░░ ░░░░░░░░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░░░░░░░░░░ ░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
Formation de Michael Wyzga
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
86
Relations au 1er degré
31
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 31 |
|---|---|
Digital Equipment Corp.
 Digital Equipment Corp. Computer Processing HardwareElectronic Technology Makes personal computers and servers | Electronic Technology |
Lotus Development Corp.
 Lotus Development Corp. Packaged SoftwareTechnology Services Provides software that helps business people collaborate across corporate networks | Technology Services |
EXACT Sciences Corp.
 EXACT Sciences Corp. Medical SpecialtiesHealth Technology Develops proprietary technologies for the detection of cancer | Health Technology |
Idenix Pharmaceuticals LLC
 Idenix Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops drugs for the treatment of human viral and infectious diseases caused by hepatitis | Health Technology |
Genzyme Corp.
 Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Health Technology |
Mereo BioPharma 5, Inc.
 Mereo BioPharma 5, Inc. Pharmaceuticals: MajorHealth Technology Develops anti-cancer stem cell therapeutics | Health Technology |
Radius Health, Inc.
 Radius Health, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops and commercializes bone health and related therapeutics | Health Technology |
Aura Biosciences, Inc.
 Aura Biosciences, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company leveraging novel targeted oncology platform to develop new standard of care across multiple cancer indications | Health Technology |
Arsanis, Inc.
 Arsanis, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which engages in developing human antibodies for treating infectious diseases | Health Technology |
X4 Pharmaceuticals, Inc. /Old/
 X4 Pharmaceuticals, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Develops and distributes oral small molecule CXCR4 antagonists | Health Technology |
Sovereign Hill Software, Inc.
 Sovereign Hill Software, Inc. Packaged SoftwareTechnology Services Supplies next generation software products | Technology Services |
Suffolk University
 Suffolk University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Providence College
 Providence College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Altus Pharmaceuticals, Inc.
 Altus Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops therapeutic products for gastrointestinal and metabolic diseases | Health Technology |
International Institute of New England, Inc.
International Institute of New England, Inc. Services to the Health IndustryHealth Services Operates charitable organization for refugees and immigrants | Health Services |
Akebia Therapeutics, Inc.
 Akebia Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops drugs for kidney diseases | Health Technology |
Prosensa Holding NV
 Prosensa Holding NV BiotechnologyHealth Technology Engages in the development of ribonucleic acid-modulating or RNA-modulating, therapeutics for the treatment of genetic disorders | Health Technology |
The Wang Center For The Performing Arts, Inc.
 The Wang Center For The Performing Arts, Inc. Internet Software/ServicesTechnology Services Provides arts, entertainment, cultural and educational experience | Technology Services |
CacheLink Corp. | |
Dohmen Co.
Dohmen Co. Data Processing ServicesTechnology Services Provides outsourced healthcare services | Technology Services |
Kew, Inc.
 Kew, Inc. Medical/Nursing ServicesHealth Services Provides oncology services | Health Services |
Gensight Biologics SA
 Gensight Biologics SA Pharmaceuticals: MajorHealth Technology Manufactures and markets novel therapies for severe retinal neurodegenerative diseases | Health Technology |
Mereo BioPharma Group Plc
 Mereo BioPharma Group Plc BiotechnologyHealth Technology Operates as a biopharmaceutical company | Health Technology |
LogicBio Therapeutics, Inc.
 LogicBio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes medicines and therapies for bone metabolism, cardiology, neurology and rare diseases | Health Technology |
Bioleap, Inc. (Florida)
Bioleap, Inc. (Florida) Engineering & ConstructionIndustrial Services Provides engineering services | Industrial Services |
Tvardi Therapeutics, Inc.
 Tvardi Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops novel and oral molecule therapies for STAT3 to treat fibrosis-driven diseases | Health Technology |
X4 Pharmaceuticals, Inc.
 X4 Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which engages in developing human antibodies for treating infectious diseases | Health Technology |
Glyscend, Inc.
Glyscend, Inc. Pharmaceuticals: MajorHealth Technology Develops oral metabolic therapeutics for the treatment of type 2 diabetes | Health Technology |
Invivyd, Inc.
 Invivyd, Inc. BiotechnologyHealth Technology Develops antibody-based solutions for infectious diseases | Health Technology |
Carina Biotech Pty Ltd.
Carina Biotech Pty Ltd. BiotechnologyHealth Technology Develops chimeric antigen receptor T-cell therapies to treat cancers | Health Technology |
Sporos Bioventures, Inc.
Sporos Bioventures, Inc. Medical/Nursing ServicesHealth Services Provides healthcare services | Health Services |
